当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:178.10亿  总市值:178.16亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.21亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1408875.39万元,未分配利润754737.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3787787.66万元,负债2378912.27万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入26,099,729,998.417,797,322,228.738,774,845,924.5738,824,430,504.85
营业总成本25,216,783,611.9917,153,291,092.838,513,876,388.4137,501,895,075.86
营业利润850,564,674.59606,652,720.96275,532,249.931,672,334,222.65
利润总额842,783,779604,023,833.45273,566,147.941,640,555,520.8
净利润620,917,976.67449,756,770.46202,880,820.281,242,120,464.96
其他综合收益-3,545,260.38-1,457,158.881,361,482.42-40,686,616.87
综合收益总额617,372,716.29448,299,611.58204,242,302.71,201,433,848.09
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计28,878,917,996.9828,691,822,636.8228,522,113,442.5428,526,182,765.44
非流动资产合计8,998,958,623.378,927,573,413.338,902,963,877.378,883,729,456.84
资产总计37,877,876,620.3537,619,396,050.1537,425,077,319.9137,409,912,222.28
流动负债合计19,912,131,853.4319,292,800,192.7518,521,658,307.6918,003,301,734.48
非流动负债合计3,876,990,851.764,357,850,134.224,811,551,265.225,518,985,043.5
负债合计23,789,122,705.1923,650,650,326.9723,333,209,572.9123,522,286,777.98
归属于母公司股东权益合计11,657,211,823.4411,569,791,063.0311,707,509,581.8611,560,548,147.45
股东权益合计14,088,753,915.1613,968,745,723.1814,091,867,74713,887,625,444.3
负债和股东权益合计37,877,876,620.3537,619,396,050.1537,425,077,319.9137,409,912,222.28
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计26,583,177,927.7617,583,177,308.758,379,859,623.5341,746,686,056.94
经营活动现金流出小计26,903,604,540.1518,269,315,032.289,586,529,531.0840,887,610,604.52
经营活动产生的现金流量净额-320,426,612.39-686,137,723.53-1,206,669,907.55859,075,452.42
投资活动现金流入小计1,514,517.12144,083.1995,20046,305,294.55
投资活动现金流出小计281,151,821.22200,157,179.8188,367,249.61362,552,304.58
投资活动产生的现金流量净额-279,637,304.1-200,013,096.62-88,272,049.61-316,247,010.03
筹资活动现金流入小计4,208,007,673.323,215,720,287.812,685,103,630.733,898,419,137.57
筹资活动现金流出小计4,581,509,564.692,994,248,643.972,447,929,143.044,624,073,630.1
筹资活动产生的现金流量净额-373,501,891.37221,471,643.84237,174,487.69-725,654,492.53
汇率变动对现金及现金等价物的影响1,887,281.63321,865.3413,495,949.262,040,757.42
现金及现金等价物净增加额-971,678,526.23-664,357,310.97-1,044,271,520.21-180,785,292.72
期末现金及现金等价物余额2,358,580,412.542,665,901,627.82,285,987,418.563,330,258,938.77
TOP↑